Preferred Hospital-SNF Relationships and Variation in Information Sharing Practices: Impact on Care Transitions for Persons with AD/ADRD
首选医院-SNF 关系和信息共享实践的变化:对 AD/ADRD 患者护理过渡的影响
基本信息
- 批准号:10427214
- 负责人:
- 金额:$ 16.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAlzheimer&aposs DiseaseAlzheimer&aposs disease careAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAwarenessBehavioralCaringClinicalCognitiveDataDiagnosisEnvironmentExhibitsHealthHealth care facilityHospitalizationHospitalsImpaired cognitionIndividualInterventionInvestmentsLinkMeasuresMedicareMedicare claimMethodsModelingNational Institute on AgingNeurobehavioral ManifestationsPathway interactionsPatient AdmissionPatient CarePatient TransferPatientsPerformancePersonsPoliciesPolicy MakerPopulationProcessResearchRiskSafetySamplingShapesSkilled Nursing FacilitiesStructureSurveysSymptomsTechnologyTimeVariantacute careadverse event riskbasedementia caredesignexperiencefinancial incentivefunctional independencehospital readmissionimprovedinsightnovelpatient populationpaymentreadmission ratessocialtransmission processusability
项目摘要
Project Summary/Abstract
Every year, over three million patients require post-acute care at a skilled nursing facility (SNF)
following hospitalization. Many of these patients are diagnosed with, or exhibit symptoms consistent with,
Alzheimer’s Disease or Alzheimer’s Disease related dementia (AD/ADRD). There is significant variation in
where and how patients are placed for SNF care, and the processes in place to support patients’ transition
to the SNF. Hospitals are increasingly aware of, and addressing, the quality deficits in these handoffs that
put patients at increased risk for adverse events and rehospitalization. As hospitals invest more in
transitional care improvements with SNFs, we explore two potential mechanisms through which variation
in how these investments are made may fail to adequately support the transitional care needs for patients
with AD/ADRD.
First, dynamics that shape SNF placement decisions for AD/ADRD patients might restrict their
access to facilities where transitional care improvements are being made. Hospitals often concentrate their
transitional care investments in the SNFs to which they regularly send patients (i.e., their high volume or
“preferred” SNFs). But, preliminary evidence suggests that these SNFs may be able to leverage their
preferred status to limit admission of patients at increased risk of complications, rehospitalization, and/or
long-term stay. These risks apply to AD/ADRD patients. We therefore must assess whether AD/ADRD
patients experience limited access to hospitals’ preferred SNFs and the transitional care investments that
are concentrated in those relationships.
Second, there is significant variation in how hospitals implement transitional care improvements,
especially with respect to how they share information to support transitions. Some hospitals routinely share
information relevant to AD/ADRD care – including cognitive status, details that inform a social/behavioral
care plan, and level of functional independence – while others do not. The variability in types of information
shared, as well as the usability and timeliness of that information, suggests that hospitals do not know how
SNFs define necessary information sharing for this population. As hospitals increasingly build new
transitional care processes using electronic methods of information sharing, it is critical to inform those
efforts with evidence on how timing and transmission of more complete patient information may better
support better AD/ADRD transitions, measured by reduced likelihood of short-term readmission.
Our study findings will inform policy makers about the potential risks of individuals with AD/ADRD
not benefiting from targeted investments to improve post-acute transitional care processes, and will provide
necessary insights in to the types of enhanced information sharing practices during patient transition that
could particularly benefit this patient population.
项目摘要/摘要
每年有300多万名患者需要在熟练的护理机构(SNF)接受急性后护理
在住院后。这些患者中的许多人被诊断为或表现出与以下症状一致的症状:
阿尔茨海默病或阿尔茨海默病相关痴呆(AD/ADRD)。有很大的不同
患者被安置在哪里以及如何接受SNF护理,以及支持患者过渡的适当流程
给特种部队。医院越来越多地意识到并解决这些移交中的质量缺陷
使患者面临更高的不良事件和再次住院风险。随着医院更多地投资于
通过SNF改善过渡期护理,我们探索了两种潜在的机制,通过这些机制
这些投资的方式可能无法充分支持患者的过渡性护理需求
使用AD/ADRD。
首先,影响AD/ADRD患者SNF放置决定的动态因素可能会限制他们的
进入正在改善过渡期护理的设施。医院经常集中他们的
对他们定期将患者送往的SNF的过渡性护理投资(即,他们的高容量或
“首选”SNF)。但是,初步证据表明,这些SNF可能能够利用他们的
优先地位,以限制并发症、再次住院和/或风险增加的患者入院
长期居留。这些风险适用于AD/ADRD患者。因此,我们必须评估AD/ADRD是否
患者体验到获得医院首选SNF和过渡性医疗投资的机会有限
都集中在这些关系上。
第二,医院实施过渡性护理改进的方式存在显著差异,
尤其是关于它们如何共享信息以支持过渡。一些医院通常会分享
与AD/ADRD护理相关的信息-包括认知状态、告知社会/行为的详细信息
护理计划和功能独立程度-而其他人则不是。信息类型的可变性
共享,以及这些信息的可用性和及时性,表明医院不知道如何
SNF为这一群体定义了必要的信息共享。随着医院越来越多地建造新的
使用信息共享的电子方法的过渡护理过程,至关重要的是告知那些
有证据表明,如何更好地安排和传输更完整的患者信息
支持更好的AD/ADRD过渡,通过降低短期重新入院的可能性来衡量。
我们的研究结果将使政策制定者了解AD/ADRD患者的潜在风险
没有受益于改善急性后过渡护理进程的有针对性的投资,并将提供
对患者过渡期间增强信息共享实践的类型的必要见解
可能会让这些患者特别受益。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dori Cross其他文献
Dori Cross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dori Cross', 18)}}的其他基金
Use of EHR Metadata to Assess Hospital Discharge Planning for Post-Acute Transitions
使用 EHR 元数据评估急性期后过渡的出院计划
- 批准号:
10429851 - 财政年份:2022
- 资助金额:
$ 16.19万 - 项目类别:
Use of EHR Metadata to Assess Hospital Discharge Planning for Post-Acute Transitions
使用 EHR 元数据评估急性期后过渡的出院计划
- 批准号:
10598578 - 财政年份:2022
- 资助金额:
$ 16.19万 - 项目类别:
Preferred Hospital-SNF Relationships and Variation in Information Sharing Practices: Impact on Care Transitions for Persons with AD/ADRD
首选医院-SNF 关系和信息共享实践的变化:对 AD/ADRD 患者护理过渡的影响
- 批准号:
10192442 - 财政年份:2021
- 资助金额:
$ 16.19万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.19万 - 项目类别:
Research Grant